V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20161534 | 20062479 | 1.61 | null | Neo-adjuvant (N) | 2016-10-22 | 2016-10-22 | ECX | 02 | N | ECX | 101515898 |
| 20161537 | 20062480 | 1.82 | 110 | Palliative (P) | null | 2019-12-09 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100142872 |
| 20161538 | 20062481 | 1.79 | 57.3 | Palliative (P) | 2019-07-02 | 2019-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101860643 |
| 20161540 | 20062482 | 1.87 | 65.3 | Neo-adjuvant (N) | 2017-03-25 | 2017-03-31 | ECX | 02 | N | ECX | 101022103 |
| 20161543 | 20062483 | 1.67 | 83.65 | Adjuvant (A) | 2016-11-14 | 2016-12-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101062803 |
| 20161545 | 20062484 | 1.7 | 100.7 | Adjuvant (A) | 2018-08-16 | 2018-08-16 | Gemcitabine + Capecitabine | null | null | CAPECITABINE + GEMCITABINE | 100856730 |
| 20161546 | 20062485 | 1.54 | 49.35 | Curative (C) | 2018-06-06 | 2018-06-19 | ECX | N | N | ECX | 100170268 |
| 20161547 | 20062486 | null | 76 | Palliative (P) | 2018-07-28 | 2018-07-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101349845 |
| 20161548 | 20062487 | 1.74 | 61.3 | Curative (C) | 2017-01-14 | 2017-01-22 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100162120 |
| 20161549 | 20062488 | 1.57 | 95.8 | Adjuvant (A) | 2017-04-26 | 2017-05-10 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100560256 |
| 20161550 | 20062489 | 1.7 | 54.8 | Adjuvant (A) | 2017-02-17 | 2017-02-17 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100286530 |
| 20161552 | 20062490 | 0 | 102.8 | Adjuvant (A) | 2019-10-02 | 2019-10-09 | ECX | 02 | N | ECX | 100236387 |
| 20161553 | 20062491 | 1.55 | 74.8 | Adjuvant (A) | 2018-07-20 | 2018-08-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101032060 |
| 20161554 | 20062492 | 1.75 | 62 | Palliative (P) | 2019-03-06 | 2019-03-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100988045 |
| 20161555 | 20062493 | null | null | Palliative (P) | 2018-12-29 | 2018-12-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100162892 |
| 20161557 | 20062494 | 1.74 | 52 | Palliative (P) | 2017-11-22 | 2017-12-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101312861 |
| 20161560 | 20062495 | 1.78 | 70.6 | Adjuvant (A) | 2019-12-23 | 2020-01-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101258252 |
| 20161561 | 20062496 | null | null | Adjuvant (A) | 2016-12-13 | 2016-12-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101324401 |
| 20161562 | 20062497 | 1.71 | 70 | Adjuvant (A) | 2016-02-29 | 2016-04-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100292528 |
| 20161563 | 20062498 | 1.56 | 57.7 | Palliative (P) | 2018-05-31 | 2018-06-27 | Gemcitabine + Capecitabine | 2 | N | ECX | 101606724 |
| 20161564 | 20062499 | 1.58 | 57.6 | Palliative (P) | 2011-06-06 | 2017-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101166075 |
| 20161568 | 20062500 | 1.66 | 74.3 | Curative (C) | 2018-11-04 | 2018-11-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100733514 |
| 20161569 | 20062501 | 1.77 | 94 | Neo-adjuvant (N) | 2018-05-26 | 2018-05-30 | Gemcitabine + Capecitabine | N | N | ECX | 100100158 |
| 20161571 | 20062502 | 1.62 | 76 | Palliative (P) | 2019-09-16 | 2019-10-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100670674 |
| 20161572 | 20062503 | 1.64 | 89.7 | Palliative (P) | 2017-05-19 | 2017-05-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101558851 |
| 20161573 | 20062504 | 1.8 | 81.6 | Palliative (P) | 2018-03-03 | 2018-03-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100759225 |
| 20161575 | 20062505 | 1.6 | 73.4 | Adjuvant (A) | 2016-11-30 | 2016-12-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101541065 |
| 20161576 | 20062506 | 1.75 | 85 | Adjuvant (A) | 2019-05-26 | 2019-06-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101832491 |
| 20161578 | 20062507 | 1.75 | 53.7 | null | 2018-01-09 | 2018-01-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100130917 |
| 20161580 | 20062508 | 1.68 | 87.9 | Adjuvant (A) | 2019-03-13 | 2019-03-17 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101738427 |
| 20161581 | 20062509 | 1.55 | 59.1 | Adjuvant (A) | 2018-04-07 | 2018-04-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101565317 |
| 20161582 | 20062510 | 1.73 | 83.6 | Neo-adjuvant (N) | 2019-02-26 | 2019-02-27 | ECX | null | N | ECX | 100833332 |
| 20161586 | 20062511 | 1.77 | 80 | Adjuvant (A) | 2019-01-17 | 2019-01-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101566924 |
| 20161587 | 20062512 | 1.76 | 66.7 | Neo-adjuvant (N) | 2019-09-10 | 2019-09-17 | ECX | N | N | ECX | 100107933 |
| 20161589 | 20062513 | 1.78 | 89.35 | Curative (C) | 2020-01-15 | 2020-01-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100646833 |
| 20161590 | 20062514 | 1.66 | 61 | Palliative (P) | 2018-10-23 | 2018-10-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101122562 |
| 20161591 | 20062515 | 1.81 | 77 | Adjuvant (A) | 2016-02-15 | 2016-02-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100328664 |
| 20161594 | 20062516 | 1.8 | 88 | Neo-adjuvant (N) | null | 2019-09-04 | Gemcitabine + Capecitabine | N | N | ECX | 100487524 |
| 20161595 | 20062517 | 1.84 | 88 | Neo-adjuvant (N) | 2019-08-16 | 2019-09-01 | ECX | N | N | ECX | 101080251 |
| 20161597 | 20062518 | null | 92.7 | Adjuvant (A) | 2017-02-11 | 2017-03-03 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101526422 |
| 20161601 | 20062519 | null | null | Adjuvant (A) | 2019-04-24 | 2019-05-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100245861 |
| 20161604 | 20062520 | 1.51 | 63.4 | Neo-adjuvant (N) | 2018-06-28 | 2018-07-06 | ECX | N | N | ECX | 100157074 |
| 20161605 | 20062521 | 1.53 | 68 | Curative (C) | 2017-05-08 | 2017-05-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100374033 |
| 20161606 | 20062522 | 1.67 | 93.55 | Neo-adjuvant (N) | 2018-08-11 | 2018-08-24 | ECX | N | null | ECX | 101851526 |
| 20161607 | 20062523 | 1.72 | 56.8 | Palliative (P) | 2017-08-29 | 2017-09-10 | ECX | null | N | ECX | 100424177 |
| 20161610 | 20062524 | null | null | Palliative (P) | 2020-01-23 | 2020-01-25 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101089456 |
| 20161612 | 20062525 | 1.68 | 85.7 | Palliative (P) | 2018-05-04 | 2018-05-04 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101537239 |
| 20161614 | 20062526 | 1.59 | 57.3 | null | 2019-07-07 | 2019-07-16 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 101408565 |
| 20161616 | 20062527 | 1.55 | 66 | Neo-adjuvant (N) | 2017-05-05 | 2017-06-04 | ECX | N | N | ECX | 100364110 |
| 20161617 | 20062528 | 1.69 | 48.6 | Palliative (P) | 2019-02-05 | 2019-02-10 | ECX | N | N | ECX | 100317330 |